Glaukos Corp (GKOS)
US$ 91.5699-0.86%
Price Chart
Key Statistics
Market Cap
$ 4.93B
P/E Ratio
0.00
Revenue (TTM)
$ 432.95M
Volume
688.99K
52W High
$ 163.71
52W Low
$ 77.10
Dividend Yield
0.00%
Beta
0.82
Technicals
50-Day MA
97.6642
200-Day MA
118.7136
52 Week High
163.71
52 Week Low
77.102
About GKOS
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and int.
Employees
995
Headquarters
Aliso Viejo, CA
CEO
Mr. Thomas William Burns
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg